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ABSTRACT 
 
Background: Mycoplasma hominis and Ureaplasma urealyticum are potentially pathogenic 
agents, playing aetiologicroles in both genital infections and infertility. In human in-vitro fertilization 
systems, the presence of U. urealyticum in either semen or female genital tract results in a decline 
of pregnancy rate per embryo transfer as well as neonatal infections. M. hominis has been 
associated with bacterial vaginosis, pelvic inflammatory disease, postabortal fever, and a number 
of gynecological infections. 
Aim: The aim of this study is to isolate, characterize and determine the antibiotic susceptibility of 
M. hominis and U. urealyticum isolates from infertile and pregnant women in Lagos, Nigeria. 
Materials and Methods: The samples were collected from Obstetrics and Gynaecology clinics of 
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Lagos University Teaching Hospital and 68 Nigerian Army reference hospital Yaba. A total of 270 
specimens of urine and HVS were collected from 135 women attending the clinics for routine 
consultations. One hundred and eighty HVS and urine specimens were from 90 married infertile 
women attending the clinics as part of a work-up for fertility investigations after failing to conceive 
for at least one year of unprotected sexual intercourse. Ninety HVS and urine specimens were from 
45 pregnant women attending the clinics for routine antenatal care. None of the subjects expressed 
any symptom of genitourinary tract infections. All the specimens were inoculated into Mycoplasma 
broth and subsequently Blood Agar plates, incubated appropriately and identified. Antibiotic 
susceptibility tests were carried out on the 52 isolates. Polymerase chain reaction (PCR) was used 
to detect the organisms in all the collected specimens. 
Results: Of the 90 HVS specimens collected from infertile women, 9 (10.0%) were positive for             
M. hominis, while 21 (23.3%) were positive for U. urealyticum. For the pregnant women using HVS 
specimens, 6 (13.3%) were positive for M. hominis while 5 (11.1%) were positive for                               
U. urealyticum. The first void urine specimens gave lower values in both the infertile and pregnant 
women. Prevalence of U. urealyticum was higher in infertile women than in pregnant women 
(p<0.05). The PCR technique gave higher values of 78.5% and 71.1% using HVS specimens for 
the infertile and pregnant women respectively for Mycoplasma/Urealyticum species. The antibiotic 
susceptibility test showed that all the isolates of M. hominis (n=18) were sensitive to Tetracycline 
(100%) and Ciprofloxacin (100%) while all the isolates of U. urealyticum (n=34) were sensitive to 
Tetracycline (100%) and Erythromycin (100%). 
Conclusion: The significantly higher prevalence of U. urealyticum infection in infertile women 
(23.3%) compared to the lower prevalence in pregnant women (11.1%) may suggest that                      
U. urealyticum can be incriminated in infertility. HVS specimen is preferred over urine specimens 
for the detection of Mycoplasma and Ureaplasma. Application of the PCR method, where 
affordable, is recommended for rapid and sensitive detection of Mycoplasma and Ureaplasma in 
HVS specimens. Tetracycline may be the antibiotic of choice, unless contraindicated, for the 
treatment of the infections, although the sample size was small. 
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1. INTRODUCTION 
 
Infertility is considered when couples have been 
trying to achieve pregnancy with frequent sexual 
intercourse for at least a year without success 
[1]. Documented data revealed that 
approximately 72.4 million couples are infertile 
[1]. The causes of 25% of the cases of infertility 
are still unknown [2]. Majority of infertile     
females have inflammatory changes of the 
oviduct or the surrounding peritoneum and     
most of these alterations are caused by 
infections [3].  
 
Generally, Mycoplasma hominis and Ureaplasma 
urealyticum have been isolated from genital 
mucosal surfaces, vagina and cervical parts of 
females [4,5,6]. U. urealyticum is a major cause 
of non-chlamydial and non-gonococcal urethritis, 
chorioamnionitis, acute prostatitis, vaginitis, 
cervicitis, preterm delivery and sepsis [6,7].                
M. hominis is often associated with vaginitis, 
cervicitis, postpartum sepsis, pyelonephritis, 
preterm labour and premature birth [8,9]. 
Bacterial vaginosis is strongly implicated in 
female infertility and screening and treatment of 
bacterial vaginosis during the course of infertility 
management increased the rate of pregnancy 
[10]. The genital Mycoplasma represent a 
complex and unique group of microorganisms 
that have been associated with a wide array of 
infectious diseases in adults and infants. These 
microorganisms particularly U. urealyticum are 
potentially pathogenic species playing etiologic 
roles in both genital infections and infertility. In 
human in vitro fertilization systems, it was 
reported that the presence of U. urealyticum in 
either semen or female genital tract resulted in a 
decline of pregnancy rates per embryo transfer 
[11], as well as neonatal infections [12]. Similarly, 
M. hominis has been associated with bacterial 
vaginosis, pelvic inflammatory disease and post 
abortal fever as well as a number of 
gynaecological infections [13]. The isolation of 
these organisms in the diagnostic laboratories is 
cumbersome and takes several days to achieve. 
The identification from clinical specimens using 
Nucleic Acid Amplification Test is very expensive 
for routine purposes. We therefore decided to 
determine the prevalence of Mycoplasma 
infections among infertile and pregnant women in 
Lagos Metropolis, Nigeria; and to determine the 
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susceptibility patterns of the isolates to some of 
the commonly prescribed antibiotics. 
 
2. MATERIALS AND METHODS 
 
2.1 Ethical Issues 
 
The study was approved by the Ethical 
Committees of Lagos University Teaching 
Hospital (LUTH) and the 68 Nigerian Army 
Reference Hospital, Yaba (68NARHY). All the 
participants signed informed consent form to 
participate in the study. 
 
2.2 Inclusion Criteria 
 
All the specimens (Urine and HVS) were from 
married infertile women attending the 
Gynecology Clinics as part of a work-up for 
fertility investigations after failing to conceive for 
at least one year of unprotected sexual 
intercourse. Also included in the study were 
expectant mothers who were normal antenatal 
clinic attendees for routine medical attention. 
Subjects with any clinical symptom of sexually 
transmitted disease were excluded from the 
study. 
 
2.3 Sample Collection 
 
From July 2012 to September 2012, a total of 
270 HVS and urine specimens were collected 
from 135 women attending the clinics for routine 
consultations. One hundred and eighty of the 
specimens were from 90 married infertile women 
attending the clinics as part of a work-up for 
fertility investigations. Ninety specimens were 
from 45 pregnant women attending the clinics for 
routine antenatal care. The subjects were aged 
between 22-45 years. The HVS specimens were 
collected by clinicians using disposable 
speculum while the subjects were informed on 
how to collect the urine specimens devoid of 
contamination. 
 
2.4 Mycoplasma hominis and Ureaplasma 
urealyticum Isolation and Identi-
fication 
 
The specimens were inoculated into the 
Mycoplasma transport/growth medium without 
delay. Clearly labelled specimens were treated 
by inoculating 0.1 ml into 5 ml of prepared 
Mycoplasma broth at the site of specimen 
collection and transported to the laboratory. The 
remaining urine specimens (about 10 ml each) 
were stored at -70°C. Both the urine and HVS 
specimens were incubated for up to 48 h at 37°C 
in 5% CO2 for Ureaplasma urealyticum and up to 
5 days for Mycoplasma hominis. These were 
examined daily for turbidity as evidence of 
growth. Subsequently, the broth cultures were 
subcultured onto solid blood agar media and 
incubated at 37°C in 5% CO 2 for 24 to 48 hours 
for Ureaplasma urealyticum and up to 5 days for 
Mycoplasma hominis. Urea for urease activities 
and L-arginine for arginine utilization were used 
for biochemical tests. Strains of M. hominis 
ATCC 23114 and U. urealyticum ATCC 33175 
were used as positive controls. Colonies 
presenting a fried egg appearance suggested the 
presence of M. hominis, while colonies that were 
brown and tiny indicated the presence of           
U. urealyticum. U. urealyticum also hydrolyzed 
urea while M. hominis metabolized the               
L. arginine [14]. 
 
2.5 Polymerase Chain Reaction 
Confirmation of U. urealyticum and M. 
hominis 
 
A PCR technique was used to detect U. 
urealyticum and M. hominis. Two millilitres of 
urine and HVS broth specimens was used Ref: 
standard strains of U. urealyticum (ATCC 
33175); M. hominis (ATCC 23114) and 
Clostridium difficile (ATCC BA-2155) were 
used.The PCR was carried out in an Eppendiof 
Nexus thermal cycler (E6331000025)with the 
following cycling parameters; an initial 
denaturation set up at 95°C for 10 minutes, 
followed by 30 consecutive cycles of 
denaturation at 95°C for 30 seconds, annealing 
at 56°C for 30 consecutive cycles. After this, a 
final extension at 72°C for 5 minutes was carried 
out. 
 
High vaginal swab (HVS) specimens and 2 ml of 
first void urine from each subject were directly 
inoculated into 5 ml of Mycoplasma broth, mixed 
and transported to the laboratory at the Nigerian 
Institute of Medical Research, (NIMR), Yaba, 
Lagos. 
 
2.6 Sample Preparation [15] 
 
Two milliliters of first void urine sample and HVS 
suspension from each of the subjects were put 
into a sterile 5ml tube and centrifuged at 13,000 
rpm for 5 minutes. The supernatant is discarded 
and the cell pellets were resuspended in 50 
microlitre of lysis buffer. After the 
homogenization, the cell pellets were incubated 
at 37°C for 15 minutes so as to lyse the cells and 
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degrade the proteins. The samples were heated 
at 95°C for 10 minutes to inactivate the protease 
and then centrifuged at 13,000 rpm for 5 minutes 
to sediment the cell debris [15]. The 
supernatants were transferred into new 
microcentrifuge tubes. Positive and negative 
controls were set up along side the kit controls. 
 
The standard strains of control organisms are; 
Ureaplasma urealyticum – ATCC 33175, 
Mycoplasma hominis – ATCC 23114, strain PG 
21, and Clostridium difficile – ATCC BA – 2155, 
Strain LBM 0801058. The primers My UU-
Forward 51– TGG AGT TAA GTC GTA ACA AG-
3 and My UU reverse r 51 – CTA AGA TGT TTC 
ACT TCA CC-3, were obtained from NIMR, 
Yaba, Lagos. 
 
2.7 PCR Reaction Setup 
 
Twenty microliters of each of the universal PCR 
mix was transferred into a tube, 2.5 microliters of 
the universal primers and 2.5 microliters of the 
test samples were added and mixed gently using 
a voltex mixer. Positive and negative samples 
were set up alongside the controls. The tools 
were placed in a thermal cycler and were taken 
through the three steps of amplification 
procedure. 
  
2.8 Gel Electrophoresis Protocol 
 
Five microliters of the PCR product is added to 
1.5 microliter of loading buffer, and mixed 
thoroughly. The samples and a DNA marker 
(1000 bp ladder) were loaded on the 3% agarose 
gel. Positive and negative controls were set up 
alongside the kit controls. Electrophoresis was 
allowed to run until the tracking dye has migrated 
60-70% of the gel length. The gel was then 
stained with ethidium bromide and viewed with 
ultraviolet illumination. 
 
The kit detects 10-9microgram quantities of target 
DNA. Samples that were positive for the 
presence of Mycoplasmas showed a distinct 
band at 434-468 bp. The positive control 
exhibited a 464 bp band while no visible band 
was noticed in the negative control lane. 
 
2.9 Antimicrobial Susceptibility Test on 
the Isolates 
 
Antimicrobial susceptibility test was carried out 
on the isolates using the modified Kirby-Bauer 
method [16] with Tetracycline (30 µg), 
Gentamycin (10 µg), Erythromycin (15 µg), 
Streptomycin (30 µg) and Ciprofloxacin (5 µg). 
Statistical analysis was done using SPSS version 
10 (computer software). 
 
3. RESULTS 
 
A total of 90 High Vaginal Swabs from infertile 
women and 45 HVS specimens from pregnant 
women were analysed using culture methods 
and PCR for M. hominis and U. urealyticum. Out 
of the 90 HVS specimens from the infertile 
women, 9 (10.0%) were positive for M. hominis 
while 21 (23.3%) were positive for                               
U. urealyticum. The urine specimens from both 
the infertile and pregnant women gave lower 
prevalences of 3.3% for M. hominis, 6.7% for                
U. urealyticum and 0.0% for M. hominis, 4.4% for 
U. urealyticum respectively (Table 1). HVS 
specimens yielded more isolates than the urine 
specimens (X2= 72.174; P<0.05). 
 
Table 2 shows the distribution of 
Mycoplasma/Ureaplasma organisms in infertile 
and pregnant women in the study area. Out of 
the 45 HVS specimens from the pregnant 
women, 32 (71.1%) were Mycoplasma/ 
Ureaplasma. The 78 analysed urine specimens 
from the infertile women gave a prevalence of 
58.9% of Mycoplasma/Ureaplasma infections. 
For the pregnant women, out of the screened 45 
urine specimens 12 (26.6%) were positive for 
Mycoplasma/Ureaplasma. 
 
The antibiotic susceptibility patterns of the M. 
hominis and U. urealyticum is shown in Table 3. 
M. hominis showed 100% sensitivity to 
Tetracycline and Ciprofloxacin while                            
U. urealyticum showed 100% sensitivity to 
Tetracycline and Erythromycin. 
 
4. DISCUSSION 
 
The results of our study showed that M. hominis 
and U. urealyticum infections are prevalent 
among the infertile and pregnant women in 
Lagos Metropolis, Nigeria. In this study both the 
HVS and Urine specimens were examined using 
culture and PCR techniques. The culture 
technique gave a prevalence, using the HVS 
specimens, of M. hominis (10.0%) and 13.3% for 
infertile and pregnant women respectively. The 
urine specimens yielded lower values for M. 
hominis with a prevalence of 3.3% and 0.0% for 
infertile and pregnant women respectively. A 
prevalence of 6.7% for infertile women and 4.4% 
for pregnant women were recorded for                        
U. urealyticum infection. The PCR technique 
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expectedly gave higher prevalence of 78.5% and 
71.1% using HVS specimens for 
Mycoplasma/Ureaplasma in infertile and 
pregnant women respectively. The urine 
specimens gave lower values of 58.9% and 
26.6% for Mycoplasma/Ureaplasma infection in 
infertile and pregnant women respectively. The 
urine specimens gave lower values of 58.9% and 
26.6% for Mycoplasma/ Ureaplasma infection in 
infertile and pregnant women respectively. One 
possible explanation for the higher prevalences 
of these infections in infertile women is hormonal 
disorders which can lead to reduced levels of 
immunity and increased bacterial colonization 
and survival in the vaginal epithelium [17]. 
 
In addition to the considerably high prevalence of 
M. hominis and U. urealyticum infections in our 
study, several published report revealed various 
prevalence rates. Agbakoba et al. [17] reported a 
prevalence of 35.7% in women of reproductive 
age in Ibadan. The prevalence rate of M. hominis 
and U. urealyticum in HVS specimens ranged 
from 0 to 3.8% [18,19]. The prevalence of                  
U. urealyticum infection was 20%, 41.9% and 
51.5% in South Africa, Italy and Africa 
respectively [18]. 
 
In a survey of 1000 female students at University 
of Calabar, Lennox et al. [20] showed that 70% 
were infected with vaginosis and vaginitis out of 
which 51% had single infection while 19% had 
mixed infections. The varied prevalence rates all 
over the world may be due to the use of only 
culture methods or PCR. In addition there are 
many factors that will affect the culture results
  
Table 1. Distribution of M. hominis and U. urealyticum in infertile (n=90) and pregnant (n=45) 
women in Lagos, Nigeria 
 
Source Organism No. of isolates Percentage 
Infertile women 
   
HVS M. hominis 9 10.0 
 U. urealyticum 21 23.3 
Urine M. hominis 3 3.30 
 U. urealyticum 6 6.70 
Pregnant women 
   
HVS M. hominis 6 13.30 
 U. urealyticum 5 11.10 
Urine M. hominis 0 0.00 
 U. urealyticum 2 4.40 
 
Table 2. Distribution of Mycoplasma/Ureaplasma species in infertile and pregnant women in 
Lagos, Nigeria using PCR 
 
Source Organism No. of isolates Percentage 
Infertile women 
   
HVS (n=65) Mycoplasma/Ureaplasma 51 78.5 
Urine (n=78) Mycoplasma/Ureaplasma 46 58.9 
Pregnant women 
   
HVS (n=45) Mycoplasma/Ureaplasma 32 71.1 
Urine (n=45) Mycoplasma/Ureaplasma 12 26.6 
 
Table 3. Antimicrobial susceptibility patterns of M. hominis and U. urealyticum isolated from 
infertile and pregnant women in Lagos, Nigeria 
 
Source Organism No. of isolates Antimicrobial agent activities % sensitive 
Te CN E CPX S 
HVS M. hominis 15 15(100) 0(0.0) 0(0.0) 15(100) 0(0.0) 
 U. urealyticum 26 26(100) 0(0.0) 26(100) 0(0.0) 0(0.0) 
Urine M. hominis 3 3(100) 0(0.0) 0(0.0) 3(100) 0(0.0) 
 U. urealyticum 8 8(100) 0(0.0) 8(100) 0(0.0) 0(0.0) 
Total  52 52(100) 0(0.0) 34(65.4) 18(34.6) 0(0.0) 
Key: Te = Tetracycline (30 µg); CN=Gentamycin (10 µg); E=Erythromycin (15 µg); CPX=Ciprofloxacin (5 µg); 
S=Streptomycin (30 µg) 
  
 
 
Ikeh et al.; MRJI, 20(1): 1-7, 2017; Article no.MRJI.33323 
 
 
 
6 
 
such as the use of transport medium, the 
duration between the collection of the sample 
and the inoculation and the duration                   
of incubation. The Nucleic Acid Amplification 
tests gave higher results due to its sensitivity and 
it is also a rapid test, although it is more 
expensive. 
 
In our study, it was observed that M. hominis and 
U. urealyticum were detected more from HVS 
than urine specimens. This is in agreement with 
Taylor-Robinson [21] who reported that the 
numbers of isolates from urine specimens were 
usually 10 fold less than in swabs. 
 
In vitro antibiotic susceptibility test showed that 
all the isolates of M. hominis and U. urealyticum 
were sensitive to Tetracycline (100%).                          
U. urealyticum isolates in addition to Tetracycline 
were all sensitive to Erythromycin, while all                 
M. hominis isolates were also sensitive to 
Ciprofloxacin. 
 
5. CONCLUSION 
 
In conclusion, our research showed that                       
M. hominis and U. urealyticum infections are 
prevalent in both the infertile and pregnant 
women in Lagos metropolis. Efforts, where 
feasible, should be made to detect the presence 
of these organisms during the work-up of cases 
of infertility and in pregnancy to prevent the 
adverse outcomes. We therefore recommend the 
precise monitoring of fertile and infertile females 
for the presence of M. hominis and                            
U. urealyticum and treatment of positive cases to 
prevent diseases and possibly infertility. 
 
The small sample size, and the lower number of 
recruited pregnant women compared with the 
infertile women are limiting factors in the present 
study. It is hoped that in future, a larger sample 
size will allow us to make definite conclusions. 
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